New Drug May Boost Effectiveness of Glioblastoma Treatment
January 25, 2024
In a new study, researchers investigated the activity of gartisertib, a potent ATR inhibitor, alone and in combination with standard therapy in multiple glioblastoma cell lines. continue reading »